BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6187588)

  • 1. Differential mitogenic effects of methyl isobutyl xanthine and a tumor growth factor on G1-arrested 3T3 T proadipocytes at the predifferentiation GD state and the growth-factor deficiency GS state.
    Scott RE; Yun K; Florine DL
    Exp Cell Res; 1983 Feb; 143(2):405-14. PubMed ID: 6187588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth arrest of proadipocytes at a distinct predifferentiation G1 state associated with cytotoxic responsiveness to 8-bromo cyclic AMP.
    Florine DL; Hoerl BJ; Scott RE
    Cell Differ; 1982 Jun; 11(4):195-202. PubMed ID: 6288270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD.
    Scott RE; Florine DL; Wille JJ; Yun K
    Proc Natl Acad Sci U S A; 1982 Feb; 79(3):845-9. PubMed ID: 6174983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topography of the predifferentiation GD growth arrest state relative to other growth arrest states in the G1 phase of the cell cycle.
    Wille JJ; Scott RE
    J Cell Physiol; 1982 Jul; 112(1):115-22. PubMed ID: 7107711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface characteristics of proadipocytes growth arrested at the predifferentiation GD state. Defects associated with neoplastic transformation.
    Boman BM; Maercklein PB; Hoerl BJ; Scott RE
    Lab Invest; 1983 Feb; 48(2):199-204. PubMed ID: 6823097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological mechanisms for the loss of the differentiated phenotype by non-terminally differentiated adipocytes.
    Hoerl BJ; Wier ML; Scott RE
    Exp Cell Res; 1984 Dec; 155(2):422-34. PubMed ID: 6209152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic transformation and defective control of cell proliferation and differentiation.
    Wille JJ; Maercklein PB; Scott RE
    Cancer Res; 1982 Dec; 42(12):5139-46. PubMed ID: 6291749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonterminally differentiated cells express decreased growth factor responsiveness.
    Hoerl BJ; Scott RE
    J Cell Physiol; 1989 Apr; 139(1):68-75. PubMed ID: 2708458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific expression of proteins and phosphoproteins in 3T3 T mesenchymal stem cells at distinct growth arrest and differentiation states.
    Sparks RL; Zschunke MA; Seibel-Ross EI; Tracy R; Zalitis JG; Boman BM; Hoerl BJ; Scott RE
    Cell Tissue Kinet; 1990 Mar; 23(2):71-87. PubMed ID: 2317836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP.
    Schmidt W; Pöll-Jordan G; Löffler G
    J Biol Chem; 1990 Sep; 265(26):15489-95. PubMed ID: 1697591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient differentiation of proadipocyte stem cells on nonadherent surfaces: evidence for differentiation without DNA synthesis.
    Yun K; Hoerl BJ; Scott RE
    J Cell Physiol; 1983 Nov; 117(2):249-56. PubMed ID: 6630301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic activity of phorbol esters and insulin-like growth factor 1 in chemically transformed mouse fibroblasts BP-A31: independent effects and differential sensitivity to inhibition by 3-isobutyl-1-methyl xanthine.
    Buchou T; Charollais RH; Fagot D; Mester J
    Exp Cell Res; 1989 May; 182(1):129-43. PubMed ID: 2469595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth arrest of AKR-2B cells maintained in the presence of epidermal growth factor or 12-O-tetradecanoylphorbol-13 acetate: evidence for two separate G1 arrest points.
    Moses HL; Proper JA; Volkenant ME; Swartzendruber DE
    J Cell Physiol; 1980 Mar; 102(3):367-78. PubMed ID: 6967071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP potentiates down regulation of epidermal growth factor receptors by platelet-derived growth factor.
    Leof EB; Olashaw NE; Pledger WJ; O'Keefe EJ
    Biochem Biophys Res Commun; 1982 Nov; 109(1):83-91. PubMed ID: 6186250
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells.
    Leof EB; Wharton W; van Wyk JJ; Pledger WJ
    Exp Cell Res; 1982 Sep; 141(1):107-15. PubMed ID: 6749535
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA; Branum EL; Volkenant ME; Moses HL
    Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic stimulation of DNA synthesis by cyclic AMP derivatives and growth factors in mouse 3T3 cells.
    Rozengurt E
    J Cell Physiol; 1982 Aug; 112(2):243-50. PubMed ID: 6288743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen response and cell cycle kinetics of Swiss 3T3 cells in defined medium: differences from human fibroblasts and effects of cell density.
    Chen YY; Rabinovitch PS
    Exp Cell Res; 1990 Oct; 190(2):145-50. PubMed ID: 2209716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of differentiation control in transformed 3T3 T proadipocytes.
    Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
    Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two subtypes of reversible cell cycle restriction points exist in cultured normal human keratinocyte progenitor cells.
    Wilke MS; Hsu BM; Scott RE
    Lab Invest; 1988 Jun; 58(6):660-6. PubMed ID: 2454348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.